Altimmune ALT Enterprise value

Enterprise value at other companies

Eli LillyLLY

$1.12T+51.8%

Merck & Co.MRK

$367.21B+59.3%

Madrigal Pharmaceuticals, Inc.MDGL

$12.46B+98.7%

VAN

Vivani MedicalVANI

$83.88M+9.2%

Viking TherapeuticsVKTX

$3.81B-14.5%

Wave Life SciencesWVE

$793.44M-9.4%

FAQ

What is Altimmune's enterprise value?

Altimmune (ALT) reported enterprise value of $337.85M in Q1 2026.

How has Altimmune's enterprise value changed year-over-year?

Altimmune's enterprise value increased by 0.5% year-over-year, from $336.17M to $337.85M.

What is the long-term trend for Altimmune's enterprise value?

Over 5 years (2020 to 2025), Altimmune's enterprise value has grown at a 1.9% compound annual growth rate (CAGR), from $335.95M to $368.56M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.